On Nov, 2019, Xantho Bio. successfully obtained a permit of IND from Taiwan TFDA. Completed Phase I on Jan 2021. Conduct clinical Phase IIa on Apr 2021 in NTUH.
(+886) 2-2655-7790
(+886) 2-2655-7730
Rm. ER12A, 17F.-1, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)